KONSTANTIN NIKIFOROV: Open Payments
NPI 1407967482 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,852 in 55 payments from 13 companies in 2025. Trend: 2023 $519 · 2024 $1,040 · 2025 $1,852
Food & beverage: $1,752Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $343 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $299 |
| ABBVIE INC. | 6 | $255 |
| E.R. Squibb & Sons, L.L.C. | 3 | $198 |
| Teva Pharmaceuticals USA, Inc. | 4 | $155 |
| Alkermes, Inc. | 7 | $153 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
Products named: Auvelity, CAPLYTA, VRAYLAR, COBENFY, REXULTI, FANAPT, LYBALVI, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
